Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study aims to catch nerve damage early in rare blood cancer

NCT ID NCT07160270

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 23 times

Summary

This study looks at why people with Waldenström's macroglobulinemia (a rare blood cancer) often develop nerve damage, causing pain, numbness, and trouble moving. Researchers will screen 90 patients to find how common this nerve damage is and what causes it. The goal is to speed up diagnosis and start treatment sooner to prevent lasting harm.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL NEUROPATHIES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Copenhagen Neuromuscular Center, Rigshospitalet Blegdamsvej.

    RECRUITING

    København Ø, 2100, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.